Treatment of secondary hyperparathyroidism with ultrasonographically guided percutaneous radiofrequency thermoablation

Surgical Laparoscopy, Endoscopy and Percutaneous Techniques

Volumn 16, Issue 2, 2006, Pages 112-116

  Carrafiello, Gianpaolo ^a   Laganà, Domenico ^a   Mangini, Monica ^a   Dionigi, Gianlorenzo ^a   Rovera, Francesca ^a   Carcano, Giulio ^a   Cuffari, Salvatore ^a   Fugazzola, Carlo ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Contrast enhanced ultrasonography; Hyperparathyroidism; Radiofrequency tissue ablation

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; PARATHYROID HYPERPLASIA; PARATHYROIDECTOMY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; SECONDARY HYPERPARATHYROIDISM; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MIDDLE AGED; PARATHYROIDECTOMY;

EID: 33748190132     PISSN: 15304515     EISSN: 15344908     Source Type: Journal    
DOI: 10.1097/00129689-200604000-00014     Document Type: Article

References (35)

1. Miccoli P, Berti P, Conte M, et al. Minimally invasive video-assisted parathyroidectomy: lesson learned from 137 cases. J Am Coll Surg. 2000;191:613-618.
2. Miccoli P, Berti P, Materazzi G, et al. Minimally invasive video assisted parathyroidectomy (MIVAP). Eur J Surg Oncol. 2003;29:188-190.
3. Berti P, Materazzi G, Picone A, et al. Limits and drawbacks of video-assisted parathyroidectomy. Br J Surg. 2003;90:743-747.
4. Inabnet WB III, Dakin GF, Haber RS, et al. Targeted parathyroidectomy in the era of intraoperative parathormone monitoring. World J Surg. 2002;26:921-925.
5. Ikeda Y, Takami H, Tajima G, et al. Total endoscopic parathyroidectomy. Biomed Pharmacother. 2002;56:22s-25s.
6. Vignali E, Picone A, Materazzi G, et al. A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases. Eur J Endocrinol. 2002;146:783-788.
7. Reeve TS, Babidge WJ, Parkyn RF, et al. Minimally invasive surgery for primary hyperparathyroidism: systematic review. Arch Surg. 2000;135:481-487.
8. Solbiati L, Giangrande A, De Pra L, et al. Percutaneous ethanol injection of parathyroid tumor under US guidance: treatment for secondary hyperparathyroidism. Radiology. 1985;155:607-610.
9. Bennedbaek FN, Karstrup S, Hegedus L. Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. Eur J Endocrinol. 1997;136:240-250.
10. Fukagawa M, Kitaoka M, Tominaga Y, et al. Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients. Nephrol Dial Transplant. 2003;18:31-33.
11. Kakuta T, Suzuki Y, Todaki F, et al. Prognosis of parathyroid function after minimally invasive radioguided parathyroidectomy (MIRP) and percutaneous ethanol injection therapy (PEIT) for primary hyperparathyroidism. Biomed Pharmacother. 2002;56:41-47.
12. Douthat WG, Orozco SE, De Arteaga J, et al. Treatment of refractory secondary hyperparathyroidism with ethanol injection: the importance of glandular volume. Kidney Int. 2003;63:101-104.
13. Tanaka R, Kakuta T, Fujisaki T, et al. Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography. Nephrol Dial Transplant. 2003;18:58-61.
14. Schamp S, Dunser E, Schuster H, et al. Ultrasound-guided percutaneous ethanol ablation of parathyroid hyperplasia: preliminary experience in patients on chronic dialysis. Ultraschall Med. 2004;25:131-136.
15. Onoda N, Kurihara S, Sakurai Y, et al. A case of secondary hyperparathyroidism whose high turnover bone improved after the direct injection of acetic acid into the parathyroid glands. Clin Nephrol. 2004;61:68-73.
16. Kitoaka M, Fukagawa M, Kurokava K. Direct injections of calcitriol into enlarged parathyroid glands in chronic dialysis patients with severe parathyroid hyperfunction. Nephrology. 1995;1:563-567.
17. Bennedbaek FN, Karstrup S, Hegedus L. Ultrasound guided laser ablation of a parathyroid adenoma. Br J Radiol. 2001;74:905-907.
18. Gazelle GS, Goldberg SN, Solbiati L, et al. Tumor ablation with radiofrequency energy. Radiology. 2000;217:633-646.
19. Pollard RE, Long CD, Nelson RW, et al. Percutaneous ultrasonographically guided radiofrequency heat ablation for treatment of primary hyperparathyroidism in dogs. J Am Vet Med Assoc. 2001;218:1106-1110.
20. Hansler J, Harsch IA, Strobel D, et al. Treatment of a solitary adenoma of the parathyroid gland with ultrasound-guided percutaneous radio-frequency-tissue-ablation (RFTA). Ultraschall Med. 2002;23:202-206.
21. Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Surgery. 1996;120:948-952.
22. Glasgow RE, Showstack JA, Katz PP, et al. The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg. 1999;134:30-35.
23. Kuo EY, Chang Y, Wright CD. Impact of hospital volume on clinical and economic outcomes for esophagectomy. Ann Thorac Surg. 2001;72:1118-1124.
24. Glance LG, Dick AW, Mukamel DB, et al. Is the hospital volume-mortality relationship in coronary artery bypass surgery the same for low-risk versus high-risk patients? Ann Thorac Surg. 2003;76:1155-1162.
25. Cowan JA Jr, Dimick JB, Wainess RM, et al. Ruptured thoracoabdominal aortic aneurysm treatment in the United States: 1988 to 1998. J Vasc Surg. 2003;38:319-322.
26. Tsukamoto Y, Nomura M, Marumo F. Pharmacological parathyroidectomy by oral 1.25 (OH) D3 pulse therapy. Nephron. 1989;51:130-131.
27. Block G, Port F. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis. 2000;35:1226-1237.
28. Malberti F, Marcelli D, Conte F. Parathyroidectomy in patients on renal replacement therapy: an epidemiological study. J Am Soc Nephrol. 2001;12:1242-1248.
29. Giangrande A, Castiglioni A, Solbiati L, et al. Ultrasound guided percutaneous fine needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant. 1992;7:412-421.
30. Fletcher S, Kanagasundaram NS, Rayner HC. Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism. Nephrol Dial Transplant. 1998;13:3111-3117.
31. Numata K, Isozaki T, Ozawa Y, et al. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma. Am J Roentgenol. 2003;180:143-149.
32. Minami Y, Kudo M, Kawasaki T, et al. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. Am J Roentgenol. 2004;183:153-156.
33. Douthat WG, Orozco SE, de Arteaga J, et al. Treatment of refractory secondary hyperparathyroidism with ethanol injection: the importance of glandular volume. Kidney Int Suppl. 2003;85:S101-S104.
34. Steddon SJ, Cunningham J. Calcimimetics and calcilytics: fooling the calcium receptor. Lancet. 2005;365:2237-2239.
35. Palazzo FF, Delbridge LW. Minimal-access/minimally invasive parathyroidectomy for primary hyperparathyroidism. Surg Clin North Am. 2004;84:717-734.